Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Berna, MJ; Tapia, JA; Sancho, V; Thill, M; Pace, A; Hoffmann, KM; Gonzalez-Fernandez, L; Jensen, RT.
Gastrointestinal growth factors and hormones have divergent effects on Akt activation.
Cell Signal. 2009; 21(4): 622-638.
Doi: 10.1016/j.cellsig.2009.01.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Hoffmann Karl Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Akt is a central regulator of apoptosis, cell growth and survival. Growth factors and some G-protein-coupled receptors (GPCR) regulate Akt. Whereas growth-factor activation of Akt has been extensively studied, the regulation of Akt by GPCR's, especially gastrointestinal hormones/neurotransmitters, remains unclear. To address this area, in this study the effects of GI growth factors and hormones/neurotransmitters were investigated in rat pancreatic acinar cells which are high responsive to these agents. Pancreatic acini expressed Akt and 5 of 7 known pancreatic growth-factors stimulate Akt phosphorylation (T308, S473) and translocation. These effects are mediated by p85 phosphorylation and activation of PI3K. GI hormones increasing intracellular cAMP had similar effects. However, GI-hormones/neurotransmitters [CCK, bombesin, carbachol] activating phospholipase C (PLC) inhibited basal and growth-factor-stimulated Akt activation. Detailed studies with CCK, which has both physiological and pathophysiological effects on pancreatic acinar cells at different concentrations, demonstrated CCK has a biphasic effect: at low concentrations (pM) stimulating Akt by a Src-dependent mechanism and at higher concentrations (nM) inhibited basal and stimulated Akt translocation, phosphorylation and activation, by de-phosphorylating p85 resulting in decreasing PI3K activity. This effect required activation of both limbs of the PLC-pathway and a protein tyrosine phosphatase, but was not mediated by p44/42 MAPK, Src or activation of a serine phosphatase. Akt inhibition by CCK was also found in vivo and in Panc-1 cancer cells where it inhibited serum-mediated rescue from apoptosis. These results demonstrate that GI growth factors as well as gastrointestinal hormones/neurotransmitters with different cellular basis of action can all regulate Akt phosphorylation in pancreatic acinar cells. This regulation is complex with phospholipase C agents such as CCK, because both stimulatory and inhibitory effects can be seen, which are mediated by different mechanisms.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Calcium - pharmacology
- Cell Line, Tumor - drug effects
- Cyclic AMP - physiology
- Enzyme Activation - drug effects
- Enzyme Inhibitors - pharmacology
- Gastrointestinal Hormones - pharmacology
- Intercellular Signaling Peptides and Proteins - pharmacology
- Male -
- Neurotransmitter Agents - pharmacology
- Pancreas - cytology
- Pancreatic Neoplasms - pathology
- Phosphatidylinositol 3-Kinases - antagonists and inhibitors
- Phosphorylation - drug effects
- Protein Kinase C - physiology
- Protein Processing, Post-Translational - drug effects
- Protein Transport - drug effects
- Proto-Oncogene Proteins c-akt - drug effects
- Rats -
- Rats, Sprague-Dawley -
- Receptor, Cholecystokinin A - drug effects
- Signal Transduction - drug effects
- Sincalide - pharmacology
- Type C Phospholipases - physiology
- src-Family Kinases - physiology
- Find related publications in this database (Keywords)
- Pancreas
- Akt
- CCK
- Phosphorylation
- Kinase
- Src
- Gastrointestinal hormones
- PI3K
- PK